Muscle strength · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Lower limb function · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Spasticity (elbow) · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Spasticity (wrist) · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Muscle strength · people with stroke
1 finding from 1 review
Death · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Upper limb function · people with stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Efficacy (functional outcome) · stroke and/or TIA
It is very uncertain whether marine‐derived n‐3 fatty acids therapy changes primary outcome: efficacy (functional outcome) compared with no marine‐derived n‐3 fatty acids therapy (very low certainty).
2 findings from 1 review
Recurrent events (both ischaemic and haemorrhagic stroke) · stroke and/or TIA
Marine‐derived n‐3 fatty acids therapy showed no clear difference in recurrent events (both ischaemic and haemorrhagic stroke) compared with no marine‐derived n‐3 fatty acids therapy (low certainty).
1 finding from 1 review
Incidence of other type of stroke ‒ not measured · stroke and/or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · stroke and/or TIA
Marine‐derived n‐3 fatty acids therapy showed no clear difference in adverse events compared with no marine‐derived n‐3 fatty acids therapy (low certainty).
2 findings from 1 review
Quality of life ‐ not measured · stroke and/or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mood · stroke and/or TIA
2 findings from 1 review
Deaths due to vascular events · stroke and/or TIA
2 findings from 1 review
Recurrent events: fatal or non‐fatal (same type of stroke, i.e. ischaemic or haemorrhagic) · stroke and/or TIA
It is very uncertain whether marine‐derived n‐3 fatty acids therapy changes recurrent events: fatal or non‐fatal (same type of stroke, i.e.… compared with no marine‐derived n‐3 fatty acids therapy (very low certainty).
1 finding from 1 review
Incidence of other type of stroke (ischaemic or haemorrhagic): fatal or non‐fatal · stroke and/or TIA
1 finding from 1 review
Health‐related quality of life · stroke and/or TIA
1 finding from 1 review
Functional outcomes · acute ischaemic stroke endovascular treatment (long‐term)
3 findings from 1 review
no estimate extracted
1 study · 90 participants
Very low
RR 1.21 [0.93, 1.58]
4 studies · 625 participants
Low
no estimate extracted
7 studies · 978 participants
Low